tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Financial Statements

470 Followers

Caribou Biosciences Financial Overview

Caribou Biosciences's market cap is currently ―. The company's EPS TTM is $-1.448; its P/E ratio is -3.49; Caribou Biosciences is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 23.66M$ 3.75M$ 3.50M$ 3.69M$ 3.30M
Gross Profit$ 23.66M$ 3.75M$ 3.50M$ 3.69M-
EBIT$ -10.00M$ -29.52M$ -28.30M$ -27.91M$ -26.54M
EBITDA-$ -31.01M$ -29.20M$ -28.31M$ -26.09M
Net Income Common Stockholders$ -10.00M$ -29.52M$ -28.04M$ -25.54M$ -26.65M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 338.49M$ 259.23M$ 228.54M$ 247.66M$ 293.37M
Total Assets$ 457.52M$ 349.65M$ 347.46M$ 373.76M$ 398.82M
Total Debt$ 27.45M$ 27.23M$ 27.42M$ 27.75M$ 27.87M
Net Debt$ -311.03M$ -232.00M$ -201.12M$ -219.92M$ -265.50M
Total Liabilities$ 59.25M$ 80.19M$ 69.19M$ 72.89M$ 74.71M
Stockholders Equity$ 398.27M$ 269.44M$ 278.27M$ 300.87M$ 324.11M
Cash Flow-
Free Cash Flow-$ -17.70M$ -29.98M$ -26.56M$ -24.03M
Operating Cash Flow$ -28.80M$ -15.14M$ -27.95M$ -25.10M$ -22.38M
Investing Cash Flow$ -68.48M$ 11.06M$ 20.70M$ 1.17M$ -8.34M
Financing Cash Flow$ 135.13M$ 17.57M$ 1.64M$ 127.00K$ 654.00K
Currency in USD

Caribou Biosciences Earnings and Revenue History

Caribou Biosciences Debt to Assets

Caribou Biosciences Cash Flow

Caribou Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis